Skip to content

Multicenter follow-up study for endovascular treatment of atherosclerostic occlusion in superfical femoral artery

Multicenter follow-up study for endovascular treatment of atherosclerostic occlusion in superfical femoral artery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-13003900
Enrollment
Unknown
Registered
2013-08-20
Start date
2012-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerotic Occlusion of Superficial Femoral Artery

Interventions

one cohort:Stent implantation

Sponsors

Vascular Department of People's hospital of Liaoning Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: The subjects that accord with diagnostic standard of atherosclerostic occlusion of lower extremity artery and imaging examinations have confirmed the SFA exist the stenosis or occlusion; Age 50-90 years old, no gender restriction.

Exclusion criteria

Exclusion criteria: 1. Expecting life span<1year; 2. The subjects with severe liver?or?kidney insufficiency or failure; 3. The subjects with stent restenosis; 4. The subjects those have allergy to aspirin, heparin, clopidogrel, statins, nickel, titarium, other elements in stent or contrast media; 5. The subjects those have hemorrhagic tendency, reactiveness reactiveness peptic ulcer, cerebral hemorrhage, subarachnoid hemorrhage and cerebral apoplexy history within 12 months,and could not receive the anticoagulant therapy with antiplatelet and anticoagulant agent due to contraindication; 6. The subjects those would receive surgical major operation within 6 months during planing to receive intervention;if the subjects are participating other study about device or drug, they could join in our study at least 30 days after subjects ended their previous following-up; 7. The subjects have the diseases those influence the following-up or restrict them join in our study.

Design outcomes

Primary

MeasureTime frame
blood routine;Coagulation function;renal function;blood glucose;blood fat;intermittent claudication distance;Ankle brachial index;Rutherford classification;TASC classification;ulcer healing time;vascular patency;post-operatve drug use;post-operative revascularizatio;

Countries

China

Contacts

Public ContactWu Danming
vsd_ln@163.com+86 13504004800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026